Perspective Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $209 | $290 | $342 |
Gross Profit | -566 | -443 | -390 | |
EBITDA | 1,549 | -25,129 | -21,147 | -17,317 |
EBIT | -25,904 | -21,880 | -18,049 | |
Net Income | -37,490 | -25,969 | -21,485 | -18,177 |
Net Change In Cash | 0 | 209 | 290 | 342 |
Free Cash Flow | -13,168 | -18,284 | -18,642 | -26,238 |
Cash | 30,629 | 26,762 | 28,849 | 44,406 |
Basic Shares | 73,813 | 74,296 | 70,671 | 72,357 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,434 | $7,104 |
Gross Profit | 1,434 | 1,634 | ||
EBITDA | 9,136 | 10,459 | -39,960 | -14,838 |
EBIT | 5,885 | -40,941 | -15,182 | |
Net Income | -103,121 | -79,279 | -46,508 | -14,670 |
Net Change In Cash | 0 | 0 | 1,434 | 7,104 |
Free Cash Flow | -95,233 | -72,708 | -37,985 | -12,474 |
Cash | 30,629 | 61,580 | 9,238 | 20,993 |
Basic Shares | 73,813 | 64,425 | 54,905 | 142,103 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.50 |
2025-09-30 | -$0.35 |
2025-06-30 | -$0.29 |
